Vaccines, Vaccination and Immunization

Vaccine Safety, Pharmacovigilance and Adverse Events

This session will address vaccine safety throughout the development and post-licensure stages. Topics will include adverse-event monitoring, pharmacovigilance systems, safety signal detection, risk assessment, benefit-risk evaluation, and post-marketing surveillance. Experts will discuss approaches for identifying and investigating potential safety concerns while maintaining public confidence in vaccination programmes. The session will also consider methods for strengthening safety monitoring systems and improving communication about vaccine safety findings. Researchers may present data from clinical studies, national surveillance programmes, and real-world vaccination settings. The session is designed for pharmacovigilance professionals, clinicians, epidemiologists, regulators, researchers, public-health specialists, and pharmaceutical representatives interested in understanding current approaches to monitoring vaccine safety and strengthening evidence-based vaccine safety systems.